T. Rowe Price Investment Management
NTLA icon

T. Rowe Price Investment Management’s Intellia Therapeutics NTLA Stock Holding History

T. Rowe Price Investment Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-533,617
Closed -$18.6M – 561
2022
Q4 		$18.6M Sell
533,617
-852
-0.2% -$29.7K 0.01% 466
2022
Q3 		$29.9M Buy
+534,469
New +$29.9M 0.02% 407